As R&D productivity declines and the age of blockbuster medicines reaches an end, the pharmaceutical industry is looking at ways to extend the profitable life of its products up to and beyond patent expiry.
29-Apr-2010 - Pfizer will lose patent protection for Viagra in Brazil on June 20 after the Supreme Court (STJ) accepted recommendations by national intellectual property watchdog, the INPI.
21-Apr-2010 - Capacity at Blu Pharmaceutical’s recently acquired solid dosage production plant in Puerto Rico is set to expand considerable over the next three years according to company president Bill Luster.
20-Apr-2010 - Irish drugmaker Elan has once again raised the possibility of selling its delivery business, Elan Drug Technologies (EDT).
15-Apr-2010 - The US Food and Drug Administration (FDA) has issued Apotex with another warning letter about cGMP violations at two plants explaining the firm’s response to previous warnings “is inadequate and...
13-Apr-2010 - US drugmaker Javelin Pharmaceuticals says Hospira’s takeover bid is “superior” and terminates agreement with Myriad Pharmaceuticals (MPI).
12-Apr-2010 - US delivery specialist Penwest is to apply its Timerx tech to “complex” generic pharmaceuticals in a development and commercialisation pact with non-branded drugmaker Alvogen.
01-Apr-2010 - Sanofi-Aventis says French manufacturing operations will focus on vaccine and biotech drugs, unveiling €150m ($202m) plan to shift emphasis away from synthetic chemistry-based production.
29-Mar-2010 - Thermo Fisher Scientific will take charge of clinical trial material production at Eli Lilly’s research technology facility in Indianapolis as the pharmaceutical firm further reduces in-house capacity to cut costs....
25-Mar-2010 - Contract manufacturing organization (CMO) ScinoPharm says strong anticancer API sales and growing demand in Europe and Asia were key to record performance in 2009.
23-Mar-2010 - A Ghanian drugmaker will soon start producing generic pharmaceuticals for the West African market, according to investment group Emerging World Pharma.
18-Mar-2010 - US pharmaceutical and biotechnology firms spent a record $65bn (€48bn) on drug and vaccine R&D in 2009, says a new study by the Pharmaceutical Research and Manufacturers of America (PhRMA)...
18-Mar-2010 - Ireland must become an R&D hub as well as a drug manufacturing destination to prosper in the increasingly competitive global pharmaceutical market, says industry body PharmaChemical Ireland (PCI).
17-Mar-2010 - Prosonix’ new UMAX particle engineering technology is set to “revolutionise” the field of respiratory medicines, according to company CEO David Hipkiss.
16-Mar-2010 - US Food and Drug Administration (FDA) request for more Afrezza data is not safety related and will not require new clinical trials, says developer MannKind.
15-Mar-2010 - Drug researchers will have greater access to some top selling molecules, including currently patented compounds atorvastatin, sildenafil and celecoxib, thanks to Sigma Aldrich’s new bioactives deal with US drug major...
15-Mar-2010 - AstraZeneca targets global generics market in license and supply deal with Indian manufacturer Torrent Pharma.
01-Mar-2010 - US FDA clearance for Italian antibiotics production facility is important for global growth says German contract development and manufacturing organisation (CDMO) Haupt Pharma.
18-Feb-2010 - US group Aptuit has bolstered its chemistry offering with a new solid state chemistry screen that it says will enable better decisions during drug formulation development and process scale-up.
17-Feb-2010 - Merck & Co says manufacturing and R&D jobs will go as part of the post acquisition workforce reduction programme it announced yesterday.
11-Feb-2010 - Generics firm Sohm says deal with manufacturer in Himachal Pradesh doubles capacity, cuts costs 6 per cent and increases profitability.
02-Feb-2010 - In-PharmaTechnologist presents a round up of recent developments in the field of drug delivery, with new deals for Starpharma and Penwest, and a regulatory filing for Hovione.
01-Feb-2010 - US generics group Watson Pharmaceuticals has bought UK contract biomanufacturing specialist Eden Biodesign.
29-Jan-2010 - AstraZeneca will cut 8,000 more jobs by 2014 with R&D and supply chain operations being the main focus of the cutbacks.
28-Jan-2010 - Crospon has spun out its transdermal controlled release patch into a distinct company, two years after it licensed the system from HP, using funding from a pharma firm to further...
26-Jan-2010 - LTS Lohmann Therapie-Systeme (LTS) signs up as manufacturer of drugs that use IntelGenx’s VersaFilm delivery technology.